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Purpose: Cited2 (CBP/p300-interacting transactivators with glutamic acid (E) and aspartic acid (D)-rich tail 2) is a
member of a new family of transcriptional modulators. Cited2 null embryos exhibit hyaloid hypercellularity consisting
of aberrant vasculature in the eye. The purpose of the study is to address whether abnormal lenticular development is a
primary defect of Cited2 deletion and whether deletion of hypoxia inducible factor (HIF)-1α or an HIF-1α target gene,
vascular endothelial growth factor (VEGF), could rescue abnormal hyaloid vascular system (HVS) in Cited2 deficient
adult eyes.
Methods: Le-Cre specific Cited2 knockout (Cited2CKO) mice with or without deletion of HIF-1α or VEGF were generated
by standard Cre-Lox methods. Eyes collected from six-eight weeks old mice were characterized by Real Time PCR and
immunohistological staining.
Results: Cited2CKO mice had smaller lenses, abnormal lens stalk formation, and failed regression of the HVS in the adult
eye. The eye phenotype had features similar to persistent hyperplastic primary vitreous (PHPV), a human congenital eye
disorder leading to abnormal lenticular development. Deletion of HIF-1α or VEGF in Cited2 knockout eyes partially
rescued the abnormal HVS but had no effect on the smaller lens and abnormal lens stalk differentiation. Intravitreal
injection  of  Topotecan  (TPT),  a  compound  that  inhibits  HIF-1α  expression,  partially  eliminated  HVS  defects  in
Cited2CKO lenses.
Conclusions: Abnormal HVS is a primary defect in Cited2 knockout mice, resulting in part from dysregulated functions
of HIF-1 and VEGF. The Cited2CKO mouse line could be used as a novel disease model for PHPV and as an in vivo model
for testing potential HIF-1 inhibitors.
The lens consists of the lens capsule, the lens epithelium,
and the lens fibers. The lens capsule is a collagen containing
basement membrane structure that completely surrounds the
lens. The lens epithelium is a simple cuboidal epithelium
between the lens capsule and the lens fibers in the anterior
portion of the lens. The lens fibers are long, thin, transparent
cells  filled  with  crystalline  proteins  to  ensure  lens
transparency [1]. Lens development begins in the ectoderm
with formation of the lens placode. In the vertebrate eye, lens
development is accompanied by the growth of the surrounding
capillary network. This network is found within the anterior
papillary membrane (APM) on the anterior surface of the lens
and includes the tunica vasculosalentis (TVL) posterior to the
lens and provides nutrients to intraocular components. The
fetal vasculature normally regresses starting late in fetal life
and completes regression in the first two weeks after birth in
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rodents  [2].  After  vascular  regression,  the  lens  becomes
transparent and resides in a hypoxic environment. However,
the role of hypoxia involved in lens development remains
elusive.
One of the major transcription factors governing hypoxic
responses  is  HIF-1,  which  is  a  heterodimeric  protein
composed  of  HIF-1α  and  HIF-1β  subunits  [3].  HIF-1α  is
degraded  through  a  proteasome-mediated  pathway  under
normoxia  but  stabilized  under  hypoxia  [4].  Stabilized
HIF-1α  dimerizes  with  HIF-1β,  binds  to  gene  promoters
containing hypoxia-response elements (HREs) and recruits
transcriptional coactivators such as CREB-binding protein
(CBP), E1A binding protein p300 (p300), or steroid receptor
coactivator-1  (SRC-1)  [5-7].  Although  hypoxia  has  been
implicated  in  controlling  normal  homeostasis  and
pathological conditions, the molecular mechanism of how
HIF-1α interacts with transcription cofactors to initiate target
gene expression is not clearly understood. As a coactivator,
CBP/p300  interacts  with  HIF-1α  through  its  cysteine/
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1260histidine-rich 1 (CH1) domain to modulate HIF-1 target gene
expression [6].
Recently, we and others found that Cited2 (CBP/p300-
interacting transactivator, with glutamic acid (E) and aspartic
acid (D)-rich tail 2), a transcriptional modulator, is a negative
regulator  for  HIF-1  through  its  competitive  binding  with
HIF-1α to the CH1 domain of CBP/p300 [8,9]. It was first
demonstrated by Bhattacharya et al. [10] based on in vitro
transfection studies that a p300 CH1 mutant peptide, defective
in  HIF-1α  but  not  Cited2  binding,  enhanced  endogenous
HIF-1 function. This notion was further supported by the
similar  nuclear  magnetic  resonance  (NMR)  structures  of
HIF-1α/p300-CH1 and Cited2/p300-CH1 complexes and the
identification of the LPXL motif in both HIF-1α and Cited2
as the basis for the competition [8]. In our studies, we showed
that Cited2 is a negative regulator of HIF-1 in embryonic heart
[9,11]  and  eye  [12]  using  Cited2  knockout  mice.  The
transcript  levels  of  HIF-1  target  genes  such  as
phosphoglycerate  kinase  1  (PGK1),  glucose  transporter  1
(Glut1), and vascular endothelial growth factor (VEGF) were
highly  expressed  in  the  Cited2−/−embryonic  heart  [9].
Furthermore, embryonic heart defects could be rescued by
HIF-1α heterozygosity in Cited2−/−embryos [11]. Similarly,
deletion of HIF-1α in the lens specifically eliminated the
hypercellularity  and  aberrant  structure  of  the  hyaloid
vasculature in Cited2−/− embryonic eyes [12]. We therefore
demonstrated that Cited2 exerts a unique feedback regulatory
mechanism to limit excess HIF-1 activation and to maintain
normal tissue homeostasis.
VEGF is one of the HIF-1target genes involved in early
vascular  development  and  angiogenesis.  It  functions  by
binding  to  the  transmembrane  tyrosine  kinase  receptor
vascular  endothelial  growth  factor  receptor-1  (VEGFR1;
Flt-1) and VEGFR2 (Flk-1, KDR) on the cell surface. Deletion
of one allele of VEGF or disruption of VEGFR2 leads to
embryonic lethality [13]. VEGF is expressed in mouse lens
epithelial and fiber cells. Overexpression of VEGF in the
mouse  lens  induces  microphthalmia,  hypertrophy,  and
persistence of the hyaloid vasculature [14]. Lenses lacking
VEGF are smaller in size with mild nuclear opacities that
regress with age [15]. Transgenic mice overexpressing stable
forms of HIF-1α in lens epithelial cells have smaller lenses at
birth  and  the  tunica  vasculosa  lentis  (TVL)  do  not  form,
although the biologic consequences of HIF-1 overexpression
or hyperactivation on the hyaloid vasculature have not been
demonstrated [16].
Persistent  hyperplastic  primary  vitreous  (PHPV),  also
known  as  persistent  fetal  vasculature,  is  a  congenital
abnormality of the eye caused by the failure of regression of
the primary vitreous [17]. During embryogenesis of human
eye, nutrients are provided by a hyaloid artery between the
retina  and  crystalline  lens,  which  is  later  replaced  by  the
developing retinal vasculature.
However, failure of regression of the primary vitreous
during third to ninth months of gestation causes PHPV [17,
18]. In most case, PHPV is sporadic and unilateral while
bilateral PHPV is rare [19]. The disease is complicated and
often  associated  with  other  ocular  abnormalities.  The
conditions that may mimic PHPV include microphthalmia,
congenital  cataract,  corneal  opacity,  uveal  coloboma,  and
retinal degeneration [17]. Although several genes, such as
protein 53 (p53) [20], alternative reading frame (Arf) [21,22],
norrie disease pseudoglioma (NDP) [23], and genes in the int
and wg (wingless; Wnt) [24] signaling pathway have been
implicated  in  the  development  of  PHPV,  the  exact
mechanisms have not been resolved.
We previously reported lens stalk formation and hyaloid
hypercellularity in Cited2 knockout mouse embryos, most
likely  through  dysregulated  HIF-1  function.  To  address
whether the phenotype is a primary defect in the lens, we
generated  tissue-specific  Cited2  knockout  mice.  Since
deletion of HIF-1α partially rescues hyaloid hypercellularity
and aberrant vasculature in Cited2 knockout embryos, we also
tested the role of HIF-1 and its target gene VEGF in lens
development by generating compound mice in which Cited2
and HIF-1α or VEGF were deleted in the lens. Based on the
fact that Cited2 is a negative regulator of HIF-1, we explored
the possibility that the Cited2CKO mouse could be an in vivo
model for testing potential HIF-1 inhibitors that may be useful
for therapies in several clinical settings.
METHODS
Animals: Cited2flox/flox (Cited2fl/fl) mice (Cited2tm1.1Dunw [25]);
with C57BL6 genetic background were mated with Le-Cre+/
−mice [26] to generate Cited2fl/fl;Le-Cre- and Cited2fl/fl;Le-Cre
+ (referred to as Cited2CKO) mice. To generate Le-Cre specific
Cited2 and HIF-1α knockout mice, Cited2fl/fl;HIF-1αfl/+ mice
were  mated  with  Cited2fl/fl;HIF-1αfl/fl;Le-Cre+  mice.  Mice
with deletion of Cited2 and VEGF in the lens were generated
by  mating  Cited2fl/fl;VEGFfl/+  mice  with  Cited2fl/fl;VEGFfl/
+;Le-Cre+/−.  Primers  for  genotyping  were:  Cited2-flox:
antisense (a), 5′-CTG CTG CTG CTG GTG ATG AT-3′ and
sense(s), 5′-GTC TCA GCG TCT GCT CGT TT-3′; Le-Cre:
(a), 5′-GCA TTA CCG GTC GAT GCA ACG AGT GAT
GAG-3′ and (s), 5′-GAG TGA ACG AAC CTG GTC GAA
ATC AGT GCG-3′; HIF-1α-flox: (a), 5′-ATA TGC TCT TAT
GAA GGG GCC TAT GGA GGC-3′ and (s), 5′-GAT CTT
TCC GAG GAC CTG GAT TCA ATT CCC-3′; VEGF-flox:
(a), 5′-ACA CAG GAC GGC TTG AAG AT-3′ and (S), 5′-
CTA CTG CCG TCC GAT TGA GA-3′.
Histology: Eyes were removed from euthanized mice and
fixed in 10% formalin at 4  0C for 24 h. Transverse 7 μm
paraffin  embedded  sections  were  collected,  hematoxylin-
eosin (H&E) stained and examined by light microscopy.
Immunofluorescence  staining:  Eyes  were  removed  and
mounted in optimal cutting temperature (OCT) immediately
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1261following sacrifice of the animal. Five μm frozen sections
were  fixed  in  4%  paraformaldehyde/PBS  for  10  min  and
blocked with 10% normal goat serum (NGS) and 0.1% Triton
X-100 in PBS for 30 min at room temperature. Sections were
incubated with primary antibodies in a humidified chamber
overnight at 4 0C. Immunostaining was performed by applying
antibodies against Cited2 (Santa Cruz, Santa Cruz, CA or R&
D,  Minneapolis,  MN),  α-smooth  muscle  actin  (α-SMA;
Sigma, St. Louis, MO), F4/80 (AbDSerotec, Raleigh, NC),
and CD31 (BD PharMingen, San Jose, CA) and detected using
Cy3-conjugated anti-mouse or anti-rat secondary antibody.
Digital  images  were  collected  using  a  Leica  DMLB
fluorescence microscope (Buffalo Grove, IL).
Pimonidazole hydrochloride (PIM) staining: Six-week old
mice  were  treated  with  PIM  (20  mg/kg  bodyweight;
HypoxyprobeTM-1; Chemicon, Billerica, MA) by intravenous
(i.v.)  injection.  Two  hours  after  injection,  mice  were
sacrificed and the eyes were immediately embedded in OCT.
Five μm thick sections were used for immunostaining with
FITC-conjugated  Mab1  antibody  (Hypoxyprobe,  Inc.
Burlington, MA).
Real Time PCR: Total RNA was extracted from lens using the
RNeasy Kit (Qiagen, Valencia, CA) and reverse transcribed
into cDNA using SuperScript First-Strand Synthesis System
for RT–PCR Kit (Invitrogen, Grand Island, NY). Real-Time
PCR was performed by using primers for Cited2: sense (s) 5′-
CGC ATC ATC ACC AGC AGC AG-3′ and antisense (a) 5′-
CGC TCG TGG CAT TCA TGT TG-3′; HIF-1α: (s) 5′-GGA
CGA TGA ACA TCA AGT CAG-3′ and (a) 5′-GGA ATG
GGT TCA CAA ATC AGC-3′; VEGF: (s) 5′-ATC TTC AAG
CCG TCC TGT GT-3′ and (a) 5′-CTG CAT GGT GAT GTT
GCT CT-3′; 18S: (s) 5′-CGT CTG CCC TAT CAA CTT
TCG-3′ and (a)5′-CCT TGG ATG TGG TAG CCG TT-3′.
Real-Time PCR was performed using iQTM SYBR Green
Supermix PCR kit and iCycler machine (Bio-Rad, Hercules,
CA). Cycling conditions were 95 °C for 10 min, and 40 cycles
of 95 °C for 15 s and 60 °C for 30 s. A melting curve analysis
of  products  was  performed  routinely  following  the
amplification to test the specificity of the PCR products. 18S
was  used  as  an  internal  control  for  normalization.  After
normalization  with  18S,  average  was  calculated  for  each
group and control in each group was set as one.
Intravitreal injection: Six- to eight-week old Cited2fl/fl;Le-
Cre-  and  Cited2CKO  mice  received  intravitreal  injection  of
Topotecan (TPT; Sigma) using a 33-gauge needle. TPT was
dissolved in dimethyl sulfoxide (DMSO) and diluted with
saline to 20 μg/μl and 40 μg/μl and 2.5 μl was injected into
each eye. In each mouse, the left eye was treated with TPT in
saline; the right eye was treated with saline containing the
same portion of DMSO to minimize the effect of DMSO used
to dissolve TPT. Right eye was used as a negative vehicle
control.  After  injection,  mouse  eyes  were  covered  with
Gentak ointment (Akorn, Inc. Lake Forest, IL) to prevent
inflammation. After 3 weeks, injected mice were euthanized
and eyes were collected for histological analysis.
RESULTS
Cited2 is important in HVS formation and regression in the
lens: To test whether the lens abnormalities in Cited2 total
knockout embryos are primary defects, Le-Cre was used to
excise the Cited2 gene in the mouse lens. Le-Cre is expressed
in the surface ectoderm from embryonic day (E) 9.5 and in
surface  ectoderm  derived  structures  including  the  lens,
cornea, conjunctiva, and the eye lid. As expected, Cited2
mRNA expression level was significantly decreased in six-
week  old  Cited2CKO  mouse  lens  compared  to  control
littermates, demonstrating the high deletion efficiency of Le-
Cre.  Since  Cited2  is  a  negative  regulator  of  HIF-1  and
VEGF is one of HIF-1 target genes, we also examined the
expression of HIF-1α and VEGF mRNAs. A modest increase
of HIF-1α and a substantial increase of VEGF transcripts were
observed in Cited2CKO mouse lenses compared to those of
control  littermates  (Figurer  1A).  Cited2CKO  mice  showed
corneal  opacity  and  the  eyes  were  smaller  than  control
littermates at six weeks of age. These mice also had lens stalks
due  to  failed  separation  of  the  lens  from  the  cornea  and
defective anterior chamber formation. In addition, abnormal
retrolental tissue was observed in Cited2CKO mouse eyes and
lenses from these mice lost their transparency (Figure 1B).
Immunostaining  showed  that  Cited2  protein  was  mainly
expressed in the nuclei of lens epithelial cells in control mouse
lenses  (Figure  1C).  Compared  with  strong  expression  of
Cited2 in control littermate lenses, Cited2CKO mice showed a
very weak signal in the disorganized lens epithelial cells. To
address  cell  types  involved  in  abnormal  HVS,
immunotstaining was performed with antibodies against α-
SMA for pericytes, F4/80 for macrophages, and CD31 for
endothelial cells. In Cited2CKO mouse eyes, positive signals
were detected for these proteins in abnormal HVS of the lens
(Figure 1D). These results indicate that Cited2 deficiency is
the primary defect during lens HVS regression.
HIF-1α controls HVS formation and regression mediated by
Cited2: To address the mechanism of Cited2 deletion-induced
abnormal hyaloid vasculature, our study focused on HIF-1
and its target gene, VEGF. Deletion of Cited2 and HIF-1α by
Le-Cre  resulted  in  lower  expression  levels  of  HIF-1α  in
Cited2fl/fl;HIF-1αfl/+ ;Le-Cre+ and Cited2fl/fl;HIF-1αfl/fl;Le-Cre
+ mice compared to control mice (Figure 2A). The VEGF
expression level was high in Cited2fl/fl;Le-Cre+ mouse lens but
decreased to the normal level in Cited2fl/fl;HIF-1αfl/fl;Le-Cre+
mouse  lens  (Figure  2B).  These  results  indicate  that  the
deletion  efficiency  of  Cited2  and  HIF-1α  by  Le-Cre  was
sufficient  to  study  phenotypes  rescued  by  deletion  of
HIF-1α.  Eyes  from  Cited2fl/fl;HIF-1αfl/fl;Le-Cre+  showed
corneal  and  lens  opacity  with  a  smaller  size  than  control
littermates  at  six  weeks  of  age  (Figure  2C).  These  mice
showed lens stalk formation and abnormal retrolental tissues.
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1262Figure 1. Le-Cre mediated deletion of Cited2 and morphological changes in Cited2CKO mice. A: Expression of Cited2 was decreased in
Cited2CKO mice compared to control (n=3, *p<0.05). Modest increase of HIF-1α and substantial increase of VEGF were observed in
Cited2CKO mice. B: Under a dissecting microscope, eyes collected from Cited2CKO mice showed smaller sizes and cornea opacity (upper panel).
H&E staining showed smaller lens, lens stalk (LS) formation at the anterior side of the lens, and hyaloid hypercellularity and aberrant
vasculature at the posterior side of the lens in Cited2CKO mice (lower panel). The insets represent higher magnification of the areas indicated
by  arrows.  C:  Immunostaining  with  Cited2  antibody  showed  decreased  expression  of  Cited2  (magenta)  in  Cited2CKO  mouse  lens.
Counterstaining with DAPI (blue) indicated that Cited2 localized in the nucleus. H&E pictures were taken at 5× magnification to show the
entire eye structure. DAPI pictures were taken at 10× using adjacent sections. Red box indicates the area shown in the Cited2/DAPI
counterstained pictures (20×). Scale bar in each picture indicates 100 μm. D: Immunostaining with α-SMA, F4/80, and CD31 (red) showed
composition of the hyaloid vascular system. Pictures were taken at 20× to show the red-boxed area. Scale bar in each picture indicates 100
μm. A↔P: anterior and posterior orientation of the eye.
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1263Interestingly,  abnormal  retrolental  tissues  disappeared  in
Cited2fl/fl;HIF-1α  fl/fl;Le-Cre+ mouse eyes even though lens
stalks persisted. This is consistent with our previous result that
deletion  of  HIF-1α  in  Cited2  knockout  embryonic  lens
specifically eliminates abnormal retrolental tissues without
affecting  the  corneal-lenticular  stalk  phenotype  [12].
Immunostaining for Cited2 showed decreased Cited2 protein
expression  in  Cited2fl/fl;HIF-1αfl/fl;Le-Cre+  mouse  lens
compared to controls (Figure 2D). Most Cited2fl/fl;HIF-1αfl/
+;Le-Cre+ mice expressed α-SMA, CD31, and F4/80 in the
posterior  lens  indicating  the  presence  of  the  pericytes,
endothelial cells, and macrophage cell types (Figure 2E).
To detect the level of local hypoxia in the absence of
Cited2 or both Cited2 and HIF-1α, we injected mice with
pimonidazole  (PIM)  [27],  a  chemical  that  interacts  with
macromolecules under hypoxia, and sacrificed mice 2 h later.
By  immunostaining,  we  observed  strong  PIM  signals  in
Cited2CKO mouse lens compared to the control mouse lens and
the lens from the negative control mouse injected with saline.
Deletion of HIF-1α in Cited2CKO mice (Cited2fl/fl;HIF-1αfl/
fl;Le-Cre+)  showed  a  weaker  PIM  signal  compared  to  the
Cited2fl/fl;Le-Cre+ mouse lens (Figure 3). This is consistent
with our previous finding that, unlike wild type embryos,
Cited2-deficient embryos remained highly hypoxic at 15.5
days post coitum (d.p.c.) in defective cardiac regions and both
the severe hypoxia and cardiovascular defects were absent
when the gene dosage of HIF-1α was reduced in Cited2-
deficient embryos [11].
Figure 2. Le-Cre mediated deletion of Cited2 and HIF-1α and phenotypic rescue by HIF-1α deletion. A: The expression levels of Cited2 and
HIF-1α were decreased in Cited2fl/fl;HIFfl/fl;Le-Cre+ mice compared to the control (n=3, *p<0.05). B: Increased VEGF in Cited2CKO resumed
to the normal level after HIF-1α was deleted in Cited2CKO mice. C: Under dissecting microscope, eyes collected from Cited2fl/fl;HIFfl/fl;Le-
Cre+ mice showed smaller sizes and cornea opacity (upper Panel). H&E staining showed smaller lens and lens stalk formation at the anterior
part of the lens in Cited2fl/fl;HIFfl/+;Le-Cre+ and Cited2fl/fl;HIFfl/fl;Le-Cre+ mice. The insets represent higher magnification of the areas indicated
by arrows. D: Expression level of Cited2 (magenta) was low in Cited2fl/fl;HIFfl/fl;Le-Cre+ mice compared to the control . H&E pictures were
taken at 5× magnification to show the entire eye structure. DAPI pictures were taken at 10× using adjacent sections. Red box indicates the
area shown in the counterstained pictures (20×). Scale bar in each picture indicates 100 μm. E: α-SMA, F4/80, and CD31 protein expression
indicated the cell types in the hyaloid vascular system. Pictures were taken at 20× to show the red-boxed area. Scale bar in each picture indicates
100 μm. A↔P: anterior and posterior orientation of the eye.
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1264To compare the rescuing efficiency of HIF-1α deficiency,
six-week old Cited2CKO and Cited2fl/fl;HIF-1αfl/+;Le-Cre+ and
Cited2fl/fl;HIF-1αfl/fl;Le-Cre+ mice were analyzed and number
of mice in each group with abnormal HVS was determined
(Table 1). All Cited2CKO mice (100%) showed abnormal HVS
formation in the lens. When one allele of HIF-1α was deleted
in Cited2CKO mice (Cited2fl/fl;HIF-1αfl/+;Le-Cre+), 71.4% of the
mice showed abnormal HVS. Interestingly, when both alleles
of  HIF-1α  were  deleted  in  Cited2CKO  mice  (Cited2fl/
fl;HIF-1αfl/fl;Le-Cre+), the number of mice with abnormal HVS
decreased to 27.3%.
Deletion  of  VEGF  partially  rescues  the  HVS  defects  in
Cited2  deficient  lens:  We  previously  observed  increased
mRNA expression of VEGF, a HIF-1 target gene, in Cited2
deficient lens [12]. To answer whether VEGF plays a role in
the formation of abnormal hyaloid vasculature induced by
Cited2 deficiency, we generated Cited2fl/fl;VEGFfl/fl;Le-Cre+
mice. Relative mRNA expression levels of Cited2 (Figure 4A)
and VEGF (Figure 4B) were decreased in Cited2fl/fl;VEGFfl/
fl;Le-Cre+ mouse lens compared to controls. Most of Cited2fl/
fl;VEGFfl/+;Le-Cre+  and  Cited2fl/fl;VEGFfl/fl;Le-Cre+  mice
showed  a  similar  phenotype  with  the  Cited2CKO  mice,
including smaller eyes, lens stalk formation, lens opacity, and
abnormal hyaloid formation (Figure 4C). Abnormal hyaloid
vasculature was observed in 100% (4/4) Cited2fl/fl;VEGFfl/
+;Le-Cre+ and 70% (7/10) Cited2fl/fl;VEGFfl/fl;Le-Cre+ mouse
lenses (Figure 4C; Table 1), although the rescuing efficiency
was not as high as with HIF-1α deletion. These results suggest
that deletion of VEGF partially rescues the phenotype induced
by Cited2 deletion but that other HIF-1 downstream genes
besides VEGF may be involved.
Cited2CKO mouse can be used as a mouse model for testing
HIF-1α  inhibitors:  Since  deletion  of  HIF-1α  significantly
rescued Cited2 deficiency induced abnormal HVS in mouse
lens, we tested whether the Cited2CKO mouse could be used as
a mouse model for testing potential HIF-1 inhibitors. Six- to
eight-week old wild type or Cited2CKO mice received once
intravitreal injection 50 μg or 100 μg of Topotecan (TPT), a
compound that inhibits the synthesis of HIF-1α, into the left
eye [28]. Saline was injected into the right eye as a negative
Figure 3. PIM staining for the hypoxic region. Eyes from different genotypes were stained with antibodies against PIM. PIM signal (Green)
was strong in Cited2CKO compared to the control. Eyes collected from Cited2fl/fl;HIFfl/fl;Le-Cre+ showed a weaker signal compared to
Cited2CKO mice. Saline injection was used as a negative control.
TABLE 1. NUMBER OF MICE WITH ABERRANT HVS FORMATION.
Genotypes Age (weeks) Lens stalk Abnormal HVS
Cited2fl/fl 6 0/8 (0%) 0/8 (0%)
Cited2fl/fl;HIF-1αfl/+/Cited2fl/fl;HIF-1αfl/fl 6 0/15 (0%) 0/15 (0%)
Cited2cko 6 7/7 (100%) 7/7 (100%)
Cited2fl/fl;HIF-1αfl/+; LeCre+ 6 5/5 (100%) 5/7 (71.4%)
Cited2fl/fl;HIF-1αfl/fl; LeCre+ 6 11/11 (100%) 3/11 (27.3%)
Cited2fl/fl;VEGFfl/+; LeCre+ 6 4/4 (100%) 4/4 (100%)
Cited2fl/fl;VEGFfl/fl; LeCre+ 6 10/10 (100%) 7/10 (70%)
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1265control. Three weeks after injection, eyes were collected and
analyzed by standard histological methods. 20% (1/5) of mice
with 50 μg of TPT injection showed less severe HVS and 25%
(2/8) of mice with 100 μg of TPT injection showed improved
HVS compared to saline injected right eyes (Figure 5). In
addition, TPT injection did not affect lens stalk formation in
the Cited2CKO mouse. These results suggest that TPT injection
partially eliminated abnormal HVS in the posterior lens in
Cited2CKO mouse.
Figure 4. Le-Cre mediated deletion of Cited2 and VEGF and phenotypic rescue by VEGF deletion. The expression level of Cited2 was decreased
in Cited2fl/fl;VEGFfl/fl;Le-Cre+ mouse lens compared to the control (n=3, *p<0.05). B: Relative VEGF mRNA expression was decreased in
Cited2fl/fl;VEGFfl/fl;Le-Cre+ mouse lens compared to Cited2CKO. C: Morphological changes were similar between Cited2CKO and Cited2fl/
fl;VEGFfl/fl;Le-Cre+ by gross examination or under dissecting microscope (upper panel). The insets represent higher magnification of the areas
indicated by arrows.
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Cited2  deficient  embryos  exhibit  several  developmental
defects  and  die  in  mid-  to  late  gestation  [9,12,29-35].
Although  Cited2  knockout  embryos  showed  lens
abnormalities [12], the mechanisms attributed to abnormal
HVS was not fully addressed. Our results in this study clearly
demonstrate that the lens abnormalities observed in Cited2
null embryos are primary defects of Cited2 deficiency in part
through the deregulation of the HIF-1 pathway.
Previous studies have shown that intraocular injection of
PIM  at  different  stages  of  development  detected  adduct
formation in all the stages examined, indicating that the lens
exists in a chronically hypoxic state throughout embryonic
development  [27].  Our  results  showed  that  the  lens  from
Cited2CKO  mouse  exists  in  a  highly  hypoxic  environment
compared to the normal lens. After deletion of HIF-1α in
Cited2CKO mice, the hypoxic levels of the lens reached normal
levels. It indicated that Le-Cre specific deletion of Cited2
affects the oxygen tension in the lens, which is consistent with
our finding in the Cited2 knockout embryonic heart [11] and
further  support  our  hypothesis  that  Cited2  is  a  negative
regulator of HIF-1.
The  transcriptional  regulator  HIF-1  is  the  master
mediator in the process of oxygen sensing and homeostasis.
Under hypoxia, cell proliferation is inhibited by stabilized
HIF-1 in cultured cells. Based on the fact that the lens is a
hypoxic organ during chick development and HIF-1α is highly
expressed in lens epithelial cells at mid-gestation in mouse
embryos,  we  tested  the  hypothesis  that  Cited2  deficiency
induced abnormal HVS in the lens is mediated by HIF-1α. In
Cited2CKO  mice,  deletion  of  HIF-1α  partially  rescued
abnormal HVS in Cited2CKO mice. The results are consistent
with our previous data that HIF-1α homozygous deletion in
the lens eliminates the aberrant HVS formation in Cited2
knockout embryonic eyes [12].
The potential role of VEGF in mediating the effect of  a
dysregulated Cited2-HIF-1 genetic interaction was suggested
by previous studies in which we showed increased VEGF
expression  in  Cited2  deficient  hearts  and  HIF-1α
haploinsufficiency not only decreased VEGF expression but
also rescued the heart defect in Cited2 deficient embryos
[11]. In the Cited2 deficient embryonic lens, we also observed
increased VEGF mRNA level. VEGF is one of the HIF-1
target  genes  that  contributes  to  the  formation  of  the
vasculature in wounded tissues and tumors. Murine VEGF
exists in three isoforms of 120, 164, and 188 amino acids
[36]. Overexpression of specific VEGF isoforms results in
different  vascular  patterning  phenotypes:  VEGF120
transgenics  show  several  vascular  patterning  defects  in
retinopathy of prematurity; VEGF164–188 transgenics show
features  consistent  with  persistent  hyperplastic  primary
vitreous (PHPV) [37,38]. Although Cited2CKO mice showed
higher expression levels of VEGF with aberrant formation of
Figure 5. Intravitreal injection of a HIF-1α inhibitor in Cited2CKO mice. Six-eight weeks old mice were received intravitreal injection of
Topotecan (TPT). Fifty or 100 μg of TPT was injected into the left eye of Cited2CKO mouse. Saline was injected into right eye as a negative
control. Representative pictures are shown for 50 μg and 100 μg of TPT injection.
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lens, it is not clear which isoform(s) are overexpressed and
responsible  for  the  vascular  phenotype.  Although  the
abnormalities were only partially corrected with deletion of
VEGF in Cited2 conditional knockout lens, it is consistent
with a previous study by Shui et al. [16] that VEGF secreted
by  lens  cells  may  stimulate  the  formation  of  the  fetal
vasculature, but regression of these vessels is not likely to be
caused by a reduction in VEGF production by the lens. It is
also possible that HIF-1 signaling could crosstalk with other
regulators, such as TGFβ family cytokines. TGFβ2 has been
shown to be an anti-angiogenic factor required for proper HVS
remodeling during development since TGFβ2 knockout mice
display aberrant HVS formation, which is similar to the HVS
phenotype in Cited2 knockout eyes and can be rescued by
overexpression  of  TGFβ1.  It  is  possible  that  decreased
expression of negative growth factors inhibiting angiogenesis,
such as TGFβ, may also contribute to the HVS phenotypes
observed in Cited2CKO mice. Consistent with such a notion,
we have previously shown that Cited2 interacts with Smads
to  modulate  TGFβ  signaling  [39,40].  A  more  thorough
expression profile analysis is necessary to identify possible
cytokines and associated pathways other than VEGF that are
involved.
Failed  regression  of  HVS  in  Cited2CKO  lens  also
associates  with  smaller  lens,  lens  opacity,  and  vitreous
abnormality.  These  characteristics  are  similar  to  the
pathological features of PHPV. Interestingly, PHPV has been
diagnosed  in  a  patient  inflicted  with  von  Hippel-Lindau
disease,  in  which   HIF-1  is   overexpressed,    suggesting    a
potential involvement of deregulated HIF-1 signaling in the
pathogenesis  of  PHPV  [41,42].  Cited2  induced  abnormal
HVS is also similar to the phenotype in Arf−/−mice. P19Arf may
directly or indirectly alter pericyte biology through repression
of  VEGF  to  destabilize  the  underlying  vessels  [22].
Interestingly, several studies have suggested a possible link
between Arf and Cited2 in other cell types, although a formal
connection  in  the  ocular  system  has  not  been  established
[43,44].
In  this  study,  the  Cited2-HIF1α  pathway  in  lens
development was further confirmed by intravitreal injection
of a HIF-1α inhibitor in Cited2CKO mice. Topotecan (TPT), a
drug that inhibits the synthesis of HIF-1α proteins, has been
used  in  clinical  trials  in  treating  ovarian  cancer  and  lung
cancer. Periocular TPT in fibrin sealant can achieve volume
reduction of small and recurrent retinoblastoma sufficient to
allow  successful  focal  therapy  [45].  Our  finding  that
intraocular injection of TPT eliminates aberrant vasculature
in Cited2CKO mice not only supports the hypothesis that the
HIF-1 pathway is involved in abnormal HVS formation but
also  provides  a  novel  mouse  model  for  testing  HIF-1
inhibitors. The major advantage of using this mouse line is
that one does not have to generate tumor-bearing mice, which
is  time-consuming.  In  addition,  only  a  small  amount  of
inhibitor  is  needed  for  intravitreal  injection,  which  is
convenient  for  screening  before  a  drug  candidate  is  fully
developed or synthesized. It is clear that TPT, like many HIF-1
inhibitors, is not a specific inhibitor. Since TPT did not affect
lens stalk formation, it is likely that TPT did not induce general
apoptosis in the injected lens, although more studies and the
use of more specific HIF-1 inhibitors as they become available
will be necessary to further validate our mouse model.
In conclusion, abnormal HVS formation in Cited2CKO
mice shows that the phenotype is a primary defect in the lens.
In addition, deletion of HIF-1α or VEGF partially rescues the
defect and HIF-1 inhibitor eliminates aberrant vasculature in
Cited2CKO mice. Based on these findings, Cited2CKO mouse
line could be used as a novel disease model for PHPV and for
testing of potential HIF-1 inhibitors.
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